There was no significant differences in SBP (142 vs 140 mmHg; p=0.93), DBP (80 vs 82 mmHg; p=0.42) and HR (71.5 vs 70.0 per min.; p=0.21) in group with and without magnesium supplementation. Pharmacological treatment and the proportion of patients that reach BP target (BP< 140/90 mmHg) were comparable in subgroup’s analysis.
Nearly half of hypertensive patients, especially women, use magnesiumsupplements regularly. Organic forms are preferable. Supplemental doses of magnesium ions did notassociate with SBP, DBP and HR values and reaching BP target in hypertensive patients.